UK Pharmaceutical Supplier and Exporter to Jordan
Jordan is one of the most mature pharmaceutical markets in the MENA region. The local JPM generics sector is strong, the JFDA is rigorous, and Amman has built a regional reputation as a medical tourism and referral hub serving patients from Iraq, Syria and the wider Levant. The gaps tend to sit elsewhere: high-cost specialty biologics, oncology pipelines, orphan drugs, paediatric oncology and the supply requirements of UNRWA and refugee health programmes. Euro Biom is an MHRA-licensed UK pharmaceutical wholesaler that works with King Hussein Cancer Center, Jordan University Hospital, Istiklal Hospital, Abdali Hospital, JFDA-registered importers and humanitarian agencies to fill those gaps with verifiable, GDP-compliant supply.
Where the Jordanian Pharmaceutical Market Has Real Gaps
JPM manufacturers cover the generics base. The pressure points sit in specialty, biologic, orphan and refugee health categories. These are the recurring gaps we hear from KHCC, Amman hospital procurement teams and UNRWA operations.
Specialty Biologics Are Slow to Reach Jordan
Newer biologics, biosimilars and targeted therapies often arrive in Jordan years after launch in Europe. JFDA registration is rigorous, originator companies prioritise larger MENA markets first, and patients at Jordan University Hospital and Abdali Hospital are left waiting.
Oncology Pipeline Gaps at KHCC and Beyond
King Hussein Cancer Center handles complex cases referred from across the region, including paediatric oncology and rare cancer subtypes. The newest targeted oncology therapies and supportive care biologics are not always available locally on the timeline patients need.
Orphan and Rare Disease Drugs Hard to Source
Rare disease patients in Jordan, including paediatric metabolic, neuromuscular and haematological cases, depend on named patient and special access routes. Local distributors do not stock these products. Importers need a UK source that knows the dossier and turnaround.
Cold Chain Risk Through Amman Summer Conditions
Biologics, insulins and vaccines need genuine cold chain integrity from Heathrow into Queen Alia International Airport, with onward distribution across Amman, Aqaba and the refugee camps. Without qualified packaging and verified loggers, hot-season transit destroys product value.
Shortage Antibiotics and Critical Care Inputs
Even in a strong market like Jordan, intermittent global shortages of specific antibiotics, sedatives and critical care medicines hit hospital ICUs. When they do, procurement teams need a same-day UK route, not a four-week tender cycle.
UNRWA and Refugee Programme Procurement Complexity
UNRWA Jordan and partner NGOs serve large refugee populations across Zaatari, Azraq and urban Amman. Donor reporting, consolidated shipments and grant-compliant documentation add layers most generic exporters cannot or will not handle.
An MHRA-Licensed UK Wholesaler Built for Jordan's Specialty Gaps
Euro Biom does not try to compete with JPM generics or with the strong local manufacturing base in Jordan. That is not where the market needs another supplier. We focus on the categories where Jordanian hospitals, JFDA-registered importers and humanitarian agencies actively need a UK pathway: specialty biologics, oncology, orphan and rare disease products, named patient access, shortage critical-care inputs, and grant-funded refugee health supply.
We hold MHRA Wholesale Dealer Authorisation WDA(H) 59239, MHRA Site Reference 37434242, and operate under UK Good Distribution Practice. Every export to Jordan ships under our own licence, with documentation prepared upfront for JFDA review and Queen Alia International Airport customs clearance. Our credentials are publicly verifiable on the MHRA register before you commit to anything.
For King Hussein Cancer Center, Jordan University Hospital and Amman private hospital groups, we respond same day on specialty and oncology enquiries. For UNRWA and refugee programmes, we structure documentation, consolidation and invoicing around grant-funded procurement and donor reporting. For JFDA importers building portfolios in specialty categories, we provide a stable, traceable UK source with predictable lead times into Amman.
Discuss Your RequirementsWhy Jordanian Buyers Choose Euro Biom as Their UK Medicine Supplier
A verifiable UK source, JFDA-aligned documentation, and a clear understanding of where Jordan's pharmaceutical market needs a partner versus where it does not.
Independently Verifiable on the MHRA Public Register
WDA(H) 59239 and Site Reference 37434242 are listed on the MHRA database. Your compliance and procurement teams can verify us before our first conversation, without relying on documents we control.
Direct Sourcing from UK GMP Manufacturers
Every batch comes from a licensed UK GMP manufacturer with full chain of custody. No layered intermediaries, no anonymous middle warehouses, no relabel-and-pass exposure. Counterfeit risk eliminated at source.
JFDA-Aligned Documentation Prepared Upfront
CPP, CFS, GMP, Certificate of Analysis, batch records and stability data are prepared before dispatch, mapped to JFDA expectations. Importers spend less time chasing missing documents after the shipment lands.
Air Freight Heathrow to Queen Alia When It Matters
Direct air freight into Amman. Urgent oncology, specialty or shortage replacement orders typically arrive in 48 to 72 hours from confirmation. Sea freight via Aqaba available where lead times allow and cost is the priority.
Cold Chain Designed for Hot Jordanian Summers
Qualified passive shippers or active containers, calibrated data loggers on every temperature-sensitive shipment, GDP documentation throughout. Insulin, biologics and vaccines arrive at KHCC, JUH or refugee health sites within label-specified ranges.
Specialty, Oncology and Orphan Drug Focus
We do not pretend to compete with JPM generics. We focus on the categories Jordanian hospitals genuinely need a UK pathway for, including biologics, biosimilars, targeted oncology and rare disease therapies.
UNRWA and Refugee Programme Experience
We support international NGOs and UN agencies running refugee health programmes serving Syrian, Iraqi and Palestinian populations in Jordan. Tender-ready dossiers, consolidated shipments and grant-compatible invoicing as standard.
5,800+ Products Across 21 Therapeutic Areas
Oncology, biologics, paediatrics, antibiotics, cardiovascular, CNS, immunology, ophthalmology and more, all sourced from UK GMP supply chains, all available for export under our WDA.
Pharmaceutical Export Services for Jordanian Hospitals and Importers
Each service is mapped to a real Jordanian scenario, not a generic catalogue. Built around named patient access, specialty biologics, hospital tenders and refugee health supply.
Named Patient and Special Access Supply
An oncologist at King Hussein Cancer Center needs a targeted therapy not yet registered in Jordan. A paediatric metabolic specialist at Jordan University Hospital needs an orphan drug. We source from licensed UK manufacturers, prepare the named patient dossier and JFDA special access documentation, and ship to Amman within days.
- Patient-specific oncology and rare disease sourcing
- JFDA special access dossier and clinician justification
- Named patient documentation pack
- Paediatric, unlicensed and orphan formulations
Specialty Biologic and Oncology Supply
JFDA-registered importers building specialty portfolios need a reliable UK source for biologics, biosimilars and oncology. We supply with full GDP cold chain integrity, batch documentation and stability data ready for JFDA submission and ongoing pharmacovigilance.
- Biologics, biosimilars and targeted therapies
- Cold chain integrity from Heathrow to Amman
- Stability and batch data for JFDA review
- Pharmacovigilance documentation support
Hospital and Tender Procurement Supply
Jordan University Hospital, Istiklal Hospital, Abdali Hospital and Ministry of Health institutions run structured procurement and tender cycles. We prepare tender packs, bid against published criteria and deliver against agreed schedules with consistent supply windows.
- Tender-ready dossiers and bid documentation
- Ministry of Health and university hospital procurement
- Institutional pricing and structured payment terms
- Consistent supply windows for chronic medicines
UNRWA, Refugee and Humanitarian Programme Supply
UNRWA Jordan, international NGOs and humanitarian agencies serving refugee populations across Zaatari, Azraq and urban Amman need consolidated, grant-compliant pharmaceutical supply. We adapt documentation, consolidation and invoicing to suit donor reporting and procurement framework requirements.
- Grant-compatible invoicing and reporting
- Consolidated humanitarian shipments
- Refugee camp and primary care formulations
- Special institutional pricing for mission-driven buyers
Trusted by Jordanian Hospitals, Importers and Humanitarian Agencies
Mission-critical pharmaceutical supply from the UK to Jordan, handled with regulatory rigour, JFDA-aligned documentation and a focus on the specialty categories the local market genuinely needs.
"We receive complex referrals from across the region, and the newest targeted oncology therapies are not always registered in Jordan on the timeline our patients need. Euro Biom handled a named patient sourcing for one of our paediatric cases, the dossier was prepared properly for JFDA review, and the medicine arrived in Amman with full cold chain documentation. That made a real difference."
"As a JFDA-registered importer building a specialty biologics portfolio, we needed a UK source whose licence we could verify independently and whose documentation would not slow us down. Euro Biom is on the MHRA register, their JFDA-aligned dossier was complete on the first shipment, and the cold chain held through an Amman summer delivery. Straightforward to work with."
"We coordinate procurement for refugee health programmes in Jordan. The donor reporting and consolidation requirements rule out most generic exporters. Euro Biom understood the brief, structured the invoicing for our grant framework, and delivered consolidated shipments into Amman on schedule. Same-day responses, every time."
How UK Pharmaceutical Export to Jordan Works
No guesswork. Each step is mapped to JFDA expectations and Queen Alia International Airport customs realities, from initial enquiry to delivery at the importer or hospital.
Send Us the Brief
Product name, strength, form, quantity, end recipient, urgency. We acknowledge the same working day. Emergency oncology or specialty requests move within 4 hours.
Stock, Pricing and Timeline Confirmed
Within 24 hours we confirm UK availability, pricing, freight option, lead time to Amman and the JFDA documentation pack required. Clear quote, no broker layers, no ambiguous follow-ups.
Documentation Built for JFDA and Customs
CPP, CFS, GMP certificates, Certificate of Analysis, batch records, stability data where required and cold chain certification are prepared and reviewed before dispatch, structured for JFDA review.
Dispatched to Amman, Tracked End to End
Air freight from Heathrow to Queen Alia International Airport, or sea freight via Aqaba where appropriate. Cold chain controlled, tracking shared, customs documentation pre-aligned. Delivered on schedule.
Questions About Importing Medicines from the UK to Jordan
Common questions from JFDA-registered importers, Jordanian hospitals, Ministry of Health teams and humanitarian agencies sourcing UK pharmaceuticals.
Ready to Source UK Specialty Medicines for Jordan?
Send us the brief. As an MHRA-licensed UK pharmaceutical exporter, we respond the same working day with availability, pricing, lead time and JFDA-aligned documentation. Focused on the specialty, oncology and named patient gaps Jordan's market actually needs filled.
MHRA WDA Licence No. WDA(H) 59239 · Company No. 15380737 · Registered England and Wales · work@eurobiom.co.uk